The following article is a part of conference coverage from the 2019 Advances in Inflammatory Bowel Diseases (AIBD) Meeting, being held in Orlando, Florida. The team at MPR will be reporting on the latest news and research conducted by leading experts gastroenterology. Check back for more from the 2019 AIBD Meeting.
Trends in the utilization of emergency department (ED) care and hospitalization among patients with inflammatory bowel disease (IBD) were investigated in a study presented at the 2019 AIBD Annual Meeting in Orlando, Florida.
Study authors analyzed data obtained from the National Inpatient Sample (NIS) and Nationwide Emergency Department Sample (NEDS) of the Healthcare Cost and Utilization Project to identify trends related to ED visits, admission rates, length of hospital stay, and associated costs in US patients with Crohn disease (CD) and ulcerative colitis (UC). “Statistical significance of the difference in emergency department visits, hospital discharges, length of stay, hospital charges, and in-hospital mortality over the years was determined by chi square test for trends,” the authors explained.
Results showed that between 2006 and 2014, the number of ED visits increased for both UC and CD patients (P =.005). Moreover, inpatient admissions also increased for both UC (P =.006) and CD patients (P =.012). “However, when comparing data from 2006 to 2014 (an era when anti-tumor necrosis factor agents were approved by the Food and Drug Administration and widely available for both CD and UC), the rates of hospitalizations did not change significantly,” the authors reported.
Additionally, the authors found that over the studied time period, there was a significant decrease in length of hospital stay (CD: 8 to 5 days; UC: 9 to 5 days; P <.001), as well as in in-hospital death (CD mortality rate: 0.65 to 0.21; UC mortality rate: 1.42 to 0.37; P <.001), however, the costs associated with hospital stay increased “dramatically” (For CD: $20,978.30 in 1993 to $38,223.50 in 2014; for UC: $24,701.20 in 1993 to $45,464.70 in 2014).
“Significant decreases in the length of stay and in-hospital mortality may reflect improved care and advancements in the treatment of IBD,” the authors concluded, adding that “Further studies on strategies that prevent complications prompting ED visits and hospital admissions are warranted.”
Tetangco, E et al; Economic Burden of Inpatient and Emergency Department Care of Inflammatory Bowel Disease. Presented at the 2019 AIBD Annual Meeting on Dec 12-14 in Orlando, FL.